Get started
Author

Kasumi Yamamoto

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program
2019 · Koji Matsumoto, Nobuo Yaegashi, et al. · Cancer Science · 37
PDF
Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer
2019 · Kazuhiro Suzuki, Shoji Nagao, et al. · Gynecologic Oncology · 37
Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors
2017 · Kasumi Yamamoto, Shoji Nagao, et al. · Gynecologic Oncology · 34
Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan
2020 · Mamiko Onuki, Koji Matsumoto, et al. · Cancer Science · 33
PDF
Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix
2015 · Shoji Nagao, Maiko Miwa, et al. · International Journal of Gynecological Cancer · 26
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
2023 · Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, et al. · Frontiers in Oncology · 23
PDF
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
2022 · Shu Yazaki, Tatsunori Shimoi, et al. · Breast Cancer Research and Treatment · 22
PDF
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
2023 · Sho Watanabe, Tatsunori Shimoi, et al. · Scientific Reports · 20
PDF
Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma
2023 · Ayumi Saito, Tadaaki Nishikawa, et al. · Gynecologic Oncology · 19
Correlation between pre-operative and final histological diagnosis on endometrial cancer
2019 · Takaya Shiozaki, Maiko Miwa, et al. · International Journal of Gynecological Cancer · 17
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
2023 · Yuki Kojima, Kazuki Sudo, et al. · Cancer Cell International · 16
PDF
A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer
2016 · Akemi Morimoto, Shoji Nagao, et al. · Japanese Journal of Clinical Oncology · 15
Early impact of the Japanese immunization program implemented before the HPV vaccination crisis
2017 · Koji Matsumoto, Nobuo Yaegashi, et al. · International Journal of Cancer · 13
PDF
Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women
2022 · Mamiko Onuki, Kasumi Yamamoto, et al. · Cancer Science · 12
Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer
2020 · Shoji Nagao, Kasumi Yamamoto, et al. · International Journal of Clinical Oncology · 12
Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study
2021 · Kasumi Yamamoto, Shoji Nagao, et al. · Journal of obstetrics and gynaecology research · 11
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
2020 · Shoji Nagao, Ai Kogiku, et al. · Journal of Ovarian Research · 11
PDF
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
2019 · Takashi Shibutani, Shoji Nagao, et al. · International Journal of Clinical Oncology · 11
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma
2021 · Kazuhiro Suzuki, Shoji Nagao, et al. · International Journal of Clinical Oncology · 9
Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine
2020 · Iwao Kukimoto, Koji Matsumoto, et al. · The Tohoku Journal of Experimental Medicine · 9
PDF
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma
2024 · Chiharu Mizoguchi, Tadaaki Nishikawa, et al. · Journal of Gynecologic Oncology · 8
PDF
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer
2023 · Jun Miyakoshi, Shu Yazaki, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 7
Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program
2022 · Mamiko Onuki, Kasumi Yamamoto, et al. · Vaccines · 7
PDF
Placental mesenchymal dysplasia differentially diagnosed from molar pregnancy by 3‐D inversion mode rendering: A case report
2013 · Ryoko Minekawa‐Mehandjiev, Kumi Masuda, et al. · Journal of obstetrics and gynaecology research · 7
The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma
2024 · Risako Ozawa, Tadaaki Nishikawa, et al. · Gynecologic Oncology Reports · 6
Works count: 64
Citation count: 478
H-index: 13
I10-index: 18
Year
Topic
Type